研究单位：[1]Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology Wuhan,Hu Bei,China,430000
研究目的：
This study is a single-center, open, dose-escalation study to observe the safety and efficacy of different doses of CAR-GPRC5D in patients with R/R MM or plasma cell leukemia.
